Is Monopar Therapeutics Inc halal to invest in?

As of July 2026, Monopar Therapeutics Inc 1IY.SG is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Monopar Therapeutics Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Monopar Therapeutics Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Monopar Therapeutics Inc?

Muslim investors may consider investing in Monopar Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Monopar Therapeutics Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Monopar Therapeutics Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Monopar Therapeutics Inc updated?

The Shariah compliance status of Monopar Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Monopar Therapeutics Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Monopar Therapeutics Inc?

You can check the latest Shariah compliance status of Monopar Therapeutics Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Monopar Therapeutics Inc 1IY.SG

Last Updated: Nov 22, 12:00 AM·XSTU

1IY.SG Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Monopar Therapeutics Inc is classified as not halal.

NOT HALAL

Report Source: 2026 1st Quarter Report

Monopar Therapeutics Inc. Stock Analysis 1IY.SG

Germany Health Care Micro Cap Report: Q1, 2026

Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. The company is headquartered in Wilmette, Illinois and currently employs 16 full-time employees. The company went IPO on 2019-12-19. The firm developing treatments for Wilson disease and novel radiopharmaceuticals for oncology. The Company’s product candidates are ALXN1840, MNPR-101, MNPR-101-Zr, MNPR-101-Lu, and MNPR-101-Ac. The Company’s Wilson disease product candidate is ALXN1840, a late-stage, investigational once-daily, oral medicine. Its radiopharmaceutical program consists of MNPR-101, a proprietary humanized monoclonal antibody that is being developed across multiple product candidates conjugated with different radioisotopes, for the treatment of advanced solid tumors. MNPR-101-Zr is the Company’s clinical-stage radiodiagnostic imaging agent comprised of MNPR-101 conjugated to zirconium-89. MNPR-101-Lu is its clinical-stage radiotherapeutic comprised of MNPR-101 conjugated to lutetium-177. MNPR-101-Ac is late-preclinical stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225.

Key Statistics of Monopar Therapeutics Inc (1IY.SG)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$18.40$18.70

Today's Open

$18.50

Volume

P/E Ratio (TTM)

Financial Metrics & Statements of Monopar Therapeutics Inc (1IY.SG)

Super Investors Invested in Monopar Therapeutics Inc (1IY.SG)

FAQ's for Monopar Therapeutics Inc (1IY.SG)

As of July 2026, Monopar Therapeutics Inc 1IY.SG is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Monopar Therapeutics Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in Monopar Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Monopar Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Monopar Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Monopar Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.